Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution DocGo Q1 2026 Earnings EPS Misses Estimates but Shares Rise PSTV Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development Bioventus BVS Q1 2026 Earnings EPS Surges Past Expectations Despite Revenue Opacity PAVmed Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Absent USPH Q1 2026 Earnings Earnings Miss Expectations as EPS Falls Short by 1725